Cushing Syndrome
Showing 1 - 25 of >10,000
Cushing Syndrome, Fatty Liver Disease Trial (hepatic MRI)
Not yet recruiting
- Cushing Syndrome
- Fatty Liver Disease
- hepatic MRI
- (no location specified)
May 25, 2023
Glucocorticoid Withdrawal Syndrome in Treated Cushing Syndrome
Recruiting
- Cushing Syndrome
- MUSE biofeedback
-
Rochester, MinnesotaMayo Clinic
Oct 31, 2022
Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome Trial run by the Crinetics Pharmaceuticals Inc. (CRN04894)
Recruiting
- Cushing Syndrome
- +2 more
-
Bethesda, MarylandNational Institutes of Health (NIH) - National Institute of Diab
Mar 27, 2023
Endogenous Cushing Syndrome Trial in Edmonton, Halifax, Sherbrooke (Intervention/Treatment)
Active, not recruiting
- Endogenous Cushing Syndrome
-
Edmonton, Alberta, Canada
- +2 more
Nov 9, 2023
Cushing Syndrome, Metabolic Syndrome Trial in Nancy (Magnetic resonance elastography (MRE))
Not yet recruiting
- Cushing Syndrome
- Metabolic Syndrome
- Magnetic resonance elastography (MRE)
-
Nancy, FranceCHRU Nancy
Jun 20, 2023
Patients With Cushing's Syndrome
Recruiting
- Cushing's Disease
- +2 more
- Cushing's QoL (Quality of Life Questionnaire)
- +10 more
-
Basking Ridge, New Jersey
- +6 more
Jan 13, 2023
Metabolic Myopathy in Endocrinopathy
Not yet recruiting
- Cushing Syndrome
- +3 more
- Muscle biopsy
- (no location specified)
Jul 12, 2022
Cortisol - Comparison of Cortisol Levels in Four Biological
Recruiting
- Adrenal Insufficiency
- +2 more
- 24 hours sampling of 4 biological fluids (blood, ISF, sweat and saliva)
- 24 hours sampling of ISF or sweat (after validating the correlation with blood)
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois (CHUV)
Aug 18, 2023
Adrenal Diseases- Laparoscopic vs. Robotic-assisted
Recruiting
- Adrenal Tumor
- +12 more
-
Olomouc, CzechiaUniversity hospital Olomouc
Sep 17, 2023
1 mg DST in Patients With Chronic Renal Failure
Completed
- Cushing Syndrome
- Dexamethasone suppression test
-
Istanbul, Pendik, TurkeyÖzlem ÜSTAY
Oct 2, 2022
Defining Genetic Basis for Development of Primary Pigmented
Completed
- Cushing's Syndrome
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Endogenous CS to Document Safety and Effectiveness of
Recruiting
- Cushing Syndrome
-
Zagreb, Croatia
- +5 more
Aug 29, 2022
Cortisol Secretion, Sensitivity and Activity and Hypertension
Recruiting
- Hypercortisolism
- Arterial Hypertension
- Dexamethasone suppression test
-
Milan, MI, ItalyIstituto Auxologico Italiano IRCCS
Mar 10, 2023
Type 2 Diabetes, Obesity and Cortisol Excess
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- 1mg DST
-
Milan, ItalyIstituto Auxologico Italiano
Mar 9, 2023
China Adrenal Disease Registry
Recruiting
- Cushing Syndrome
- +7 more
-
Shanghai, ChinaEndocrinology
Jan 28, 2022
Cushing Syndrome, Tumors Trial (Dabigatran Etexilate, Relacorilant)
Not yet recruiting
- Cushing Syndrome
- Neoplasms
- Dabigatran Etexilate
- Relacorilant
- (no location specified)
Apr 22, 2022
Adrenal Tumour With Mild Hypercortisolism Trial in Denmark, Norway, Sweden (Adrenalectomy)
Recruiting
- Adrenal Tumour With Mild Hypercortisolism
- Adrenalectomy
-
Århus, Denmark
- +3 more
Jan 11, 2023
Adrenal and Other Endocrine Tumors in Patients With Sudden Death
Recruiting
- Primary Aldosteronism
- +3 more
- Adrenal aldosterone synthase (CYP11B2) staining
- +2 more
-
Helsinki, FinlandEndocrinology, Helsinki University Hospital and University of He
Jul 8, 2022
Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Nodular Hyperplasia, Adrenal Cushing
Completed
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- +4 more
-
Uppsala, SwedenUppsala University Hospital
Apr 29, 2022
Quality of Life, Fatigue and Cognitive, Affective and Emotional
Recruiting
- Cushing Syndrome
-
Leiden, Netherlands
- +2 more
Jun 21, 2021
Hypercortisolism, Diabetes, Type 2 Trial (Mifepristone 300 MG [Korlym], Placebo for mifepristone)
Not yet recruiting
- Hypercortisolism
- Diabetes Mellitus, Type 2
- Mifepristone 300 MG [Korlym]
- Placebo for mifepristone
- (no location specified)
Mar 6, 2023
Novel Mediators of Lipodystrophy and Metabolic Consequences of
Completed
- Cushing's Syndrome
- Treatment of Cushing's
-
New York, New YorkColumbia University Neuroendocrine Unit
Jul 12, 2021